Knowledge and Perception of Clinical Trial Participation in Breast Cancer Patients in Egypt

Overview

– Clinical trials are essential to translate new therapy concepts or rather any intervention into the medical routine. Beside the well designed trial protocol, the success of clinical trials depends on patient recruitment and participation. – This study aims to get a current picture of the patients' knowledge and perception of clinical trial participation in Breast cancer female patients in Egypt, as an example to Low/Middle income countries.

Full Title of Study: “Knowledge and Perception of Clinical Trial Participation in Breast Cancer Female Patients in Egypt, a Cross Sectional Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: December 2020

Interventions

  • Behavioral: Knowledge and perception of clinical trial participation
    • This study aims to get a current picture of the patients’ knowledge and perception of clinical trial participation in Breast cancer female patients in Egypt, as an example to Low/Middle income countries

Clinical Trial Outcome Measures

Primary Measures

  • The percentage of breast cancer patients who accept to participate in clinical trials
    • Time Frame: 1 year

Secondary Measures

  • The barriers for participation in clinical trials
    • Time Frame: 1 year

Participating in This Clinical Trial

Inclusion Criteria

  • Female breast cancer patients Exclusion Criteria:

  • Patients who refuse participation

Gender Eligibility: Female

Minimum Age: N/A

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ain Shams University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Hagar Elghazawy, Lecturer of clinical oncology – Ain Shams University
  • Overall Official(s)
    • Hagar Elghazawy, Principal Investigator, Ain shams university, faculty of medicine
  • Overall Contact(s)
    • Hagar Elghazawy, MD, 01006232406, dr.hagar.elghazawy@med.asu.edu.eg

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.